Is Travere Therapeutics, Inc. overvalued?

Travere Therapeutics, Inc. (TVTX) — key valuation metrics and fundamentals.

No verdict

Price

$50.65

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$4.86B

Dividend yield

0.0%

Return on equity

-186.5%

Sector

Healthcare

Fair value compares TVTX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks